ALLURION TECHNOLOGIES, INC. (ALUR): Nasdaq/NYSE listing notice — Allurion appeals NYSE delisting; trading moves to OTC; FDA approval of balloon catalyst for relisting plan

ALLURION TECHNOLOGIES, INC.

NYSE notified Allurion on March 6, 2026 of delisting for failing to maintain $15M average global market cap over 30 consecutive days.
Trading suspended after March 6, 2026; common stock and warrants now trade on OTCID Market under ALUR and ALUR.WS.
Company appealed delisting determination and will attempt to regain compliance with NYSE or list on NYSE American.
FDA approval of Allurion Gastric Balloon System (Feb 20, 2026) catalyzed plan to strengthen balance sheet and fund U.S. commercialization.
CEO Dr. Shantanu Gaur expressed confidence in executing the plan to treat obesity in over 100M Americans.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

ALLURION TECHNOLOGIES, INC. received a nyse delisting notice notice regarding market value (rules 802.01B).

Exchange: nyse
Notice: delisting notice
Deficiency: market value
Rules: 802.01B

Exact text from the filing

March 6, 2026, the New York Stock Exchange (“NYSE”) notified Allurion Technologies, Inc. (“Allurion” or the “Company”) that it has determined to commence proceedings to delist the Company’s common stock, par value $0.0001 per share (the “Common Stock”), and warrants to purchase 0.056818 shares of Common Stock, with an exercise price of $202.50 per share of Common Stock (the “Warrants”), as a result of the Company’s non-compliance with Rule 802.01B of the NYSE Listed Company Manual that requires listing companies to maintain an average global market capitalization of at least $15 million over a

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ALLURION TECHNOLOGIES, INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-104434

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.